Induction of cytotoxic T lymphocytes by immunization with dengue virus - Derived, modified epitope peptide, using dendritic cells as a peptide delivery system

Dengue Bulletin

Volumn 28, Issue , 2004, Pages 145-150

  Fujii, Yoshiki ^a   Masaki, Hideyuki ^b   Tomura, Takanori ^b   Irimajiri, Kiyohiro ^a   Kurane, Ichiro ^c  

^a KINKI UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Binding motif; Cytotoxic T lymphocyte; Dendritic cell; Dengue virus; Epitope; Peptide

Indexed keywords

AMINO ACID; DENGUE VIRUS PROTEIN 1; DENGUE VIRUS PROTEIN 2; EPITOPE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DENGUE; DENGUE VIRUS; DNA BINDING MOTIF; DRUG DELIVERY SYSTEM; DRUG PULSE THERAPY; FEMALE; IMMUNIZATION; MOUSE; MOUSE STRAIN; NONHUMAN; PROTEIN MOTIF; SEROTYPE; STRAIN DIFFERENCE; TARGET CELL; VIRUS STRAIN;

ANIMALIA; CELL FUSING AGENT VIRUS; DENGUE VIRUS; MURINAE;

EID: 19044362474     PISSN: 1020895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Gotch F, Gallimore A and McMichael A. Cytotoxic T cells - protection from disease progression - protection from infection. Immunol Lett, 1996, 51: 125-128.
2. Toes RE, van der Voort EI, Schoenberger SP, Drijfhout JW, van Bloois L, Storm G, Kast WM, Offringa R and Melief CJ. Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells. J Immunol, 1998, 160: 4449-4456.
3. BenMohamed L, Belkaid Y, Loing E, Brahimi K, Gras-Mass H and Druihe P. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant. Eur J Immunol, 2002, 32: 2274-2281.
4. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol, 1991, 9: 271-296.
5. Ludewig B, Ehl S, Karrer U, Odermatt B, Hengartner H and Zinkernagel RM. Dendritic cells efficiently induce protective antiviral immunity. J Virol, 1998, 72: 3812-3818.
6. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelope derived peptide-pulsed dendritic cells. Int Immunol, 1993, 5: 849-857.
7. Porgador A, Snyder D and Gilboa E. Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol, 1996, 156: 2918-2926.
8. + T-cell clones specific for the dengue virus NS3 protein: flavivirus cross-reactivity and influence of infecting serotype. J Virol, 1999, 73: 398-403.
9. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K and McKenna HJ. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J Exp Med, 1996, 184: 1953-1962.
10. Son YI, Egawa S, Tatsumi T, Redlinger RE Jr, Kalinski P and Kanto T. A novel bulk-culture method for generating mature dendritic cells from mouse bone marrow cells. J Immunol Methods, 2002, 262: 145-157.
11. d -restricted antigenic peptides share a simple binding motif. J Exp Med, 1991, 174: 603-612.